exogenous administration of bcaa as part of a total parenteral nutrition ( tpn ) regimen has been proposed to compensate for the altered protein metabolism in the stressed patient by sparing endogenous sources of bcaa , thereby reducing skeletal muscle catabolism and increasing protein synthesis .
C0002520
bcaa
C0002521
bcaa